Innovus Pharmaceuticals (OTCQB:INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced the launch of its product AllerVarx™, which is a clinically proven, Natural Health Product approved by Health Canada to help reduce symptoms of allergic … Continued
The post Innovus Pharma Announces the Launch of Its Product AllerVarx in Canada for Allergic Rhinitis appeared first on Investing News Network.